Alliancebernstein L.P. Exact Sciences Corp Transaction History

Alliancebernstein L.P.

  • $287 Billion
  • Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Exact Sciences Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 960,592 shares of EXAS stock, worth $54 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
960,592
Previous 958,369 0.23%
Holding current value
$54 Million
Previous $40.5 Million 61.53%
% of portfolio
0.02%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$42.43 - $70.83 $94,321 - $157,455
2,223 Added 0.23%
960,592 $65.4 Million
Q2 2024

Aug 14, 2024
BUY
$41.33 - $74.26 $36.3 Million - $65.3 Million
878,674 Added 1102.55%
958,369 $40.5 Million
Q1 2024

May 14, 2024
SELL
$56.27 - $73.77 $1.96 Million - $2.57 Million
-34,897 Reduced 30.45%
79,695 $5.5 Million
Q4 2023

Feb 14, 2024
BUY
$59.06 - $75.72 $2.23 Million - $2.85 Million
37,698 Added 49.03%
114,592 $8.48 Million
Q3 2023

Nov 14, 2023
BUY
$65.94 - $99.04 $6,000 - $9,012
91 Added 0.12%
76,894 $5.25 Million
Q2 2023

Aug 15, 2023
SELL
$62.68 - $95.05 $44,001 - $66,725
-702 Reduced 0.91%
76,803 $7.21 Million
Q1 2023

May 15, 2023
SELL
$47.19 - $70.77 $394,980 - $592,344
-8,370 Reduced 9.75%
77,505 $5.26 Million
Q4 2022

Feb 14, 2023
BUY
$30.35 - $53.15 $96,330 - $168,698
3,174 Added 3.84%
85,875 $4.25 Million
Q3 2022

Nov 15, 2022
SELL
$31.97 - $49.37 $11,221 - $17,328
-351 Reduced 0.42%
82,701 $2.69 Million
Q2 2022

Aug 15, 2022
BUY
$35.61 - $76.23 $178,085 - $381,226
5,001 Added 6.41%
83,052 $3.27 Million
Q1 2022

May 13, 2022
SELL
$57.56 - $82.54 $83,289 - $119,435
-1,447 Reduced 1.82%
78,051 $5.46 Million
Q4 2021

Feb 14, 2022
SELL
$72.5 - $100.68 $400,345 - $555,954
-5,522 Reduced 6.49%
79,498 $6.19 Million
Q3 2021

Nov 10, 2021
SELL
$90.24 - $124.05 $152,415 - $209,520
-1,689 Reduced 1.95%
85,020 $8.12 Million
Q2 2021

Jul 30, 2021
BUY
$93.66 - $139.27 $217,478 - $323,384
2,322 Added 2.75%
86,709 $10.8 Million
Q1 2021

May 06, 2021
SELL
$116.57 - $155.01 $19,583 - $26,041
-168 Reduced 0.2%
84,387 $11.1 Million
Q4 2020

Feb 08, 2021
BUY
$99.61 - $142.12 $117,340 - $167,417
1,178 Added 1.41%
84,555 $11.2 Million
Q3 2020

Nov 12, 2020
BUY
$72.92 - $102.01 $172,820 - $241,763
2,370 Added 2.93%
83,377 $8.5 Million
Q2 2020

Aug 13, 2020
BUY
$55.75 - $92.75 $297,314 - $494,635
5,333 Added 7.05%
81,007 $7.04 Million
Q1 2020

May 14, 2020
SELL
$37.9 - $104.44 $599,047 - $1.65 Million
-15,806 Reduced 17.28%
75,674 $4.39 Million
Q4 2019

Feb 18, 2020
SELL
$77.66 - $99.74 $24.7 Million - $31.7 Million
-317,515 Reduced 77.63%
91,480 $8.46 Million
Q3 2019

Nov 14, 2019
SELL
$90.37 - $122.49 $97.3 Million - $132 Million
-1,076,864 Reduced 72.47%
408,995 $37 Million
Q2 2019

Aug 14, 2019
SELL
$89.51 - $118.04 $30.1 Million - $39.6 Million
-335,881 Reduced 18.44%
1,485,859 $175 Million
Q1 2019

May 14, 2019
SELL
$61.98 - $96.5 $27.6 Million - $42.9 Million
-445,058 Reduced 19.63%
1,821,740 $158 Million
Q4 2018

Feb 13, 2019
SELL
$56.04 - $82.66 $640,257 - $944,390
-11,425 Reduced 0.5%
2,266,798 $143 Million
Q3 2018

Nov 08, 2018
SELL
$48.29 - $80.6 $10 Million - $16.7 Million
-207,259 Reduced 8.34%
2,278,223 $180 Million
Q2 2018

Aug 13, 2018
SELL
$37.84 - $69.96 $7.39 Million - $13.7 Million
-195,423 Reduced 7.29%
2,485,482 $149 Million
Q1 2018

May 14, 2018
BUY
$39.82 - $57.53 $97.3 Million - $141 Million
2,442,295 Added 1023.55%
2,680,905 $108 Million
Q4 2017

Feb 13, 2018
BUY
$46.49 - $60.51 $110,181 - $143,408
2,370 Added 1.0%
238,610 $12.5 Million
Q3 2017

Nov 13, 2017
BUY
$37.05 - $47.12 $8.75 Million - $11.1 Million
236,240
236,240 $11.1 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.95B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email